In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Aethlon Medical, Inc.. Trade Record

NASDAQ:AEMD Aethlon Medical, Inc. stock gains 6.26% Exit Feb 7, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart AEMD Jan 30, 2017, priceSeries
About Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Its Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. The company is also involved in developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. Aethlon Medical, Inc. was founded in 1991 and is based in San Diego, California.

Trade Information
Trade Type
Entry Date
Jan 30, 2017
Entry Price
Sell Date
Feb 7, 2017
Sell Price
Net Gain
Hold Time
6 Trading Days